Skip to main content

MRI Grows as the Place for Biotech Firms to Get Noticed


When Agilent’s automated lab-on-chip platform (ALP) Bioanalyzer 5100 underwent high-throughput screening at the Midwest Research Institute in December 2004, it joined a cadre of other technology companies that take advantage of MRI’s established profile as a reliable provider of testing for novel technologies.

The ALP is available as part of Invitrogen’s PATH Alert System, a microfluidic-based kit for chemical and biological threat agent detection, and Invitrogen and other companies have used MRI’s abilities to do “real-world testing” on their products before, spokespeople for the institute said.

According to Linda Cook, a spokesperson for MRI, the Kansas City, Mo.-based institute does not endorse new technologies, but rather is contracted by companies like Agilent to perform testing on technology that the company cannot do itself.

That lack of endorsement doesn’t mean that the performance of a technology of a product isn’t noted. According to Victor Truong, a spokesperson for Agilent, getting the ALP tested at MRI was part of a concentrated effort to make the technology, only available since November 2004, visible in places where it counts.

— JP

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.